From the Research
Yes, losartan can cause hyponatremia, as evidenced by a case report of losartan-induced severe hyponatremia in a 73-year-old patient 1.
Mechanism and Risk Factors
Losartan, an angiotensin II receptor blocker (ARB), can lead to hyponatremia by affecting kidney function and sodium reabsorption. It works by blocking the renin-angiotensin-aldosterone system, which can reduce sodium retention and potentially lower serum sodium levels, especially in susceptible individuals such as the elderly or those taking other medications that affect sodium balance.
- Amlodipine, a calcium channel blocker, has a lower risk of causing hyponatremia but can occasionally contribute to it through vasodilation effects that may influence fluid balance.
- Patients taking either medication should be monitored for symptoms of hyponatremia such as confusion, headache, nausea, muscle weakness, or seizures, particularly if they have risk factors like advanced age, kidney disease, or are taking diuretics concurrently.
Monitoring and Management
Regular blood tests to check electrolyte levels are advisable, especially when starting these medications or adjusting dosages.
- The most recent study comparing amlodipine and losartan found that amlodipine is more effective than losartan in treating essential hypertension, with a greater reduction in systolic and diastolic blood pressure 2.
- However, the primary concern in this context is the potential for losartan to cause hyponatremia, as highlighted in the 2015 case report 1.
Conclusion Not Applicable
Instead, the focus should be on prioritizing the single most recent and highest quality study, which in this case is the 2024 comparative efficacy and safety study of amlodipine and losartan 2, while also considering the specific risk of hyponatremia associated with losartan as reported in the 2015 case study 1.